# Combination Therapy of Anthracyclines for Children With Nephroblastoma

> **NCT03892330** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 120 (estimated)

## Conditions studied

- 0.5-14 Year Old Children With Nephroblastoma

## Interventions

- **DRUG:** Vincristine
- **DRUG:** Oxytetracycline/ Cyclophosphamide
- **DRUG:** Liposomal doxorubicin
- **DRUG:** Doxorubicin
- **DRUG:** Pharmorubicin
- **DRUG:** Pirarubicin

## Key facts

- **NCT ID:** NCT03892330
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2019-06-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2045-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892330, "Combination Therapy of Anthracyclines for Children With Nephroblastoma". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03892330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*